The AI revolution is already here — but what does it mean for patients, clinicians, and health care industry leaders? Eric Larsen, veteran health care strategist and longtime advisor to CEOs across the industry, joins host Chip Kahn for a discussion about why the U.S. health care industry is uniquely exposed to AI-driven disruption and…
Kardigan was able to upsize its IPO, raising more cash for three drug candidates in mid-stage clinical development for cardiovascular conditions with no available therapies. All three programs are expected to report key data in 2027 that could pave the way for Phase 3 testing. The post Kardigan’s IPO Lands $400M for Drugs That Get…
Mount Sinai Health System is betting on Microsoft’s Dragon Copilot as its ambient scribing tool of choice, a decision that followed competitive tests against rival vendors Abridge and Suki. Lisa Stump, Mount Sinai’s chief digital information officer, noted that the health system has been transparent with Microsoft that their partnership may change given Epic’s launch…
The healthcare investor conference, scheduled for May 20 and 21 at the Willis Tower in Chicago, combines panel discussions, networking opportunities, and a startup pitch contest. Register today! The post Who is Speaking at INVEST 2025? appeared first on MedCity News.
Effective specimen collection during the pivotal collection period guides everything that follows, from individual therapeutic decisions to large-scale community outbreak control. The post The 96-Hour Advantage: Why Early Diagnostic Accuracy Defines Clinical Outcomes appeared first on MedCity News.
A year ago, a new head of Social Security set out to stop the agency from financially devastating many of the people it was meant to help. The agency had long made it a practice to reduce or halt benefit checks to recoup billions of dollars in payments it sent recipients but later said they…
As reported by Kaiser Health News: The value of drugmakers’ copay cards has become more unpredictable as insurers try to restrict their use. Many insurance plans, for instance, do not count the money from a copay program toward a patient’s deductible.And patients who use a copay card can wind up paying full or nearly full price…
Montana Gov. Greg Gianforte’s administration is reviving efforts to do away with a panel that hears appeals from people who were denied public assistance to afford basics such as food and health care. The effort, billed as a way to reduce red tape in government, would leave district court as the only option outside of…
To fully capitalize on its potential, laboratories must ensure they understand how to use AI effectively. Without this understanding, there’s a risk of undermining the technology’s benefits and potentially harming the industry as a whole. The post Harnessing AI in Pathology: A Vital Tool That Requires Careful Ownership appeared first on MedCity News.
Akero Therapeutics reported that at 96 weeks, 39% of patients who received the 50 mg dose of efruxifermin achieved improvement in fibrosis, or liver scarring, caused by the fatty liver disease MASH. This study previously failed to achieve statistically significant improvement at 36 weeks, but Akero executives say the latest results show that longer dosing…